Basic principles for the study of metastasis using animal models

S A Eccles1

  • 1CRC Centre for Cancer Therapeutics, McElwain Laboratories, Institute of Cancer Research, Surrey, UK.

Insights

Clinically relevant metastasis models are now available, improving cancer research. Older models like mouse ascites tumors poorly mimic solid tumor spread, hindering drug development for metastasis.

Area of Science:

  • Oncology
  • Cancer Metastasis Research

Background:

  • Metastasis is a primary driver of cancer treatment failure.
  • Historically, cancer research relied on limited rodent tumor models.
  • The development of clinically relevant metastasis models has been a recent advancement.

Purpose of the Study:

  • To highlight the limitations of traditional cancer models in metastasis research.
  • To emphasize the need for improved models that accurately reflect solid tumor metastasis.
  • To explain why past drug development efforts have been ineffective against solid tumors.

Main Methods:

  • Review of historical cancer research models, including transplanted rodent tumors (e.g., B16F10, Lewis lung carcinoma).
  • Critique of the National Cancer Institute (NCI) anticancer drug screening assays.
  • Comparison of mouse ascites tumors with solid tumor metastasis in vivo.

Main Results:

  • Traditional models, like intravenous injection of B16F10 cells, primarily yielded lung colonies.
  • Mouse ascites tumors, used in the NCI screen, are poor models for solid tumors.
  • The limitations of ascites models explain the lack of effective drugs for solid tumor metastases.

Conclusions:

  • The availability of diverse, clinically relevant metastasis models is crucial for advancing cancer treatment.
  • Past reliance on inadequate models like mouse ascites tumors has hampered the development of anti-metastasis therapies.
  • Future drug discovery must utilize models that accurately represent the complexity of solid tumor metastasis.